LeMaitre Vascular (LMAT) to Release Quarterly Earnings on Thursday

LeMaitre Vascular (NASDAQ:LMAT) is set to issue its quarterly earnings data after the market closes on Thursday, October 31st. Analysts expect the company to announce earnings of $0.44 per share for the quarter. Parties interested in listening to the company’s conference call can do so using this link.

LeMaitre Vascular (NASDAQ:LMAT) last announced its quarterly earnings results on Thursday, August 1st. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.47 by $0.05. The company had revenue of $55.85 million for the quarter, compared to analyst estimates of $54.98 million. LeMaitre Vascular had a net margin of 18.33% and a return on equity of 12.41%. The firm’s revenue was up 11.4% on a year-over-year basis. During the same period in the previous year, the firm posted $0.37 EPS. On average, analysts expect LeMaitre Vascular to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

LeMaitre Vascular Price Performance

Shares of NASDAQ:LMAT opened at $90.41 on Wednesday. LeMaitre Vascular has a one year low of $45.96 and a one year high of $93.32. The company has a market cap of $2.03 billion, a price-to-earnings ratio of 59.87, a PEG ratio of 2.29 and a beta of 0.88. The firm has a 50 day simple moving average of $89.33 and a 200 day simple moving average of $82.50.

LeMaitre Vascular Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, August 29th. Stockholders of record on Thursday, August 15th were paid a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.71%. The ex-dividend date of this dividend was Thursday, August 15th. LeMaitre Vascular’s payout ratio is 42.38%.

Analyst Upgrades and Downgrades

LMAT has been the subject of a number of recent research reports. Lake Street Capital initiated coverage on LeMaitre Vascular in a report on Friday, August 2nd. They issued a “buy” rating and a $105.00 target price for the company. StockNews.com downgraded shares of LeMaitre Vascular from a “buy” rating to a “hold” rating in a research report on Tuesday, August 27th. JMP Securities boosted their target price on shares of LeMaitre Vascular from $77.00 to $100.00 and gave the stock a “market outperform” rating in a report on Tuesday, August 20th. Cantor Fitzgerald assumed coverage on shares of LeMaitre Vascular in a research note on Tuesday, October 15th. They set a “neutral” rating and a $96.00 price target for the company. Finally, Barrington Research reiterated an “outperform” rating and set a $92.00 price target on shares of LeMaitre Vascular in a report on Friday, September 20th. Three analysts have rated the stock with a hold rating, five have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, LeMaitre Vascular has an average rating of “Moderate Buy” and a consensus price target of $94.67.

Insider Transactions at LeMaitre Vascular

In other LeMaitre Vascular news, Director David B. Roberts sold 3,063 shares of the company’s stock in a transaction on Tuesday, August 13th. The shares were sold at an average price of $82.07, for a total transaction of $251,380.41. Following the sale, the director now owns 14,114 shares of the company’s stock, valued at approximately $1,158,335.98. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 10.79% of the stock is currently owned by corporate insiders.

About LeMaitre Vascular

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.